Customer Center

Samyang News

Samyang News
Samyang Holdings Biopharmaceuticals Division’s “Croquis” Wins 2021 Red Dot Design Award Print
Affiliates Samyang Holdings Biopharmaceuticals Division Writer administrator Hits 908 Date 2021.08.26

- Winner of the 2021 Red Dot Design Award, one of the world’s top three design awards
- Line drawn product packaging with black lines against a white background displaying brand significance and features
- Five different yet unified designs for each product type


▲ Product packaging of Croquis, a facelift thread brand of Samyang Holdings Biopharmaceuticals Division, which was awarded the 2021 Red Dot Design Award (for brands and communication design). The line drawing method visually depicts the brand significance, aimed at quickly and naturally shaping facial contours. Each design displays uniqueness and creativity, yet a unified look.


Samyang Holdings (CEO: Eum Tae-woong) Biopharmaceuticals Division announced on Aug. 23 that Croquis won the 2021 Red Dot Design Award (for brands and communication design). Croquis is a facelift thread brand of Samyang Holdings Biopharmaceuticals Division.


Since 1955, Design Zentrum Nordrhein Westfalen has led the Red Dot Design Award, one of the world’s top three design awards along with iF Product Design Award and the International Design Excellence Awards. In this award ceremony, the best design is selected annually based on its excellence, creativity, and functionality in three divisions: product design, brands and communication design, and design concept. In 2021, 7,800 artworks were exhibited in roughly 60 countries, and 50 design experts conducted a blind evaluation.


The product packaging of Samyang Holdings Biopharmaceuticals Division’s Croquis was inspired by “croquis,” a rough sketch that brings out the object’s characteristics. It earned high points and awarded as winner for an artistic and visual depiction of the brand identity that resonates with consumers and increases customers’ satisfaction.


Croquis product packaging features a sketch of various facial angles using a “line drawing” technique, marking various black lines against a white background. The brand identity was effectively and naturally conveyed through this technique, as the product quickly and naturally and beautifully shapes facial contours. In addition, five different drawing methods were applied for each design, which was unique yet unified.

A spokesperson from Samyang Holdings Biopharmaceuticals Division said, “We made sure the design intuitively displayed the brand significance and features of Croquis at a glance. We will continue to develop designs that are easy for consumers to understand and provide differentiated use convenience.”


Meanwhile, Croquis gained trust from the global cosmetic surgery industry by reasonable, data-based marketing, earning its second-mover advantage. Currently, Croquis is sold in roughly 10 countries, including Germany and the UK, and various promotions and academic marketing are being implemented in each nation through webinars to reach cosmetic surgery medical teams worldwide.

이전 다음글 제목을 나타낸 표
Prev Samyang Biopharm USA and Spanish National Research Council to Conduct Joint Research on Mechanism of New Drug Candidates 2021.09.03
Next Samyang Data Systems Signs MOU with OSC Korea 2021.08.24